CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 262 filers reported holding CLOVIS ONCOLOGY INC in Q3 2017. The put-call ratio across all filers is 0.57 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $65,000 | -82.3% | 11,261 | -78.5% | 0.00% | -84.6% |
| Q1 2021 | $368,000 | -89.8% | 52,396 | -74.0% | 0.03% | -87.1% |
| Q4 2018 | $3,614,000 | +99.3% | 201,218 | +939.3% | 0.20% | +176.7% |
| Q2 2017 | $1,813,000 | -59.9% | 19,361 | -72.7% | 0.07% | -69.2% |
| Q1 2017 | $4,524,000 | +44.7% | 71,047 | +109.0% | 0.24% | +238.6% |
| Q3 2015 | $3,126,000 | +57.8% | 33,997 | +4.3% | 0.07% | +29.6% |
| Q3 2013 | $1,981,000 | – | 32,596 | – | 0.05% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Healthcare Value Capital, LLC | 150,000 | $1,564,000 | 4.60% |
| Healthcare Value Capital, LLC | 100,000 | $1,043,000 | 3.07% |
| Palo Alto Investors LP | 5,056,286 | $52,712,000 | 2.90% |
| HIGHBRIDGE CAPITAL MANAGEMENT LLC | 1,328,200 | $13,848,000 | 1.53% |
| Ikarian Capital, LLC | 513,700 | $5,355,000 | 0.87% |
| Pinz Capital Management, LP | 207,800 | $2,166,000 | 0.79% |
| Leap Investments LP | 146,300 | $1,525,000 | 0.72% |
| Elk Creek Partners, LLC | 574,616 | $5,990,000 | 0.69% |
| SECTOR GAMMA AS | 408,625 | $4,260,000 | 0.68% |
| Artal Group S.A. | 1,000,000 | $10,425,000 | 0.40% |